- Transfusion-associated graft-versus-host disease
- Immunocompromised patients
- Hematologic malignancies or certain solid tumors
- Recipients of marrow or peripheral blood stem cell transplantation
- Patients receiving blood components from blood relatives or human leukocyte antigen-compatible donors
- Patients receiving fludarabine therapy
- Prematurity, low birthweight, or erythroblastosis fetalis in newborn
Oct
26
2021